Figure 2.

Kaplan-Meier curves and 95% confidence bands for time to in-hospital death or transfer to hospice among patients hospitalized for coronavirus disease 2019 (COVID-19), not requiring supplemental oxygen at admission, across the COVID-19 variant time periods. Sample sizes for the nonremdesivir group are weighted because matching with replacement approach was used. Time after baseline refers to the time during which outcomes were assessed after the 2-day period in which remdesivir treatment administration was identified (baseline).